Dataset Information

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.

ABSTRACT: A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromodomain inhibitors with excellent activity against leukemic cells, concomitant with a reduction in c-MYC expression. These novel benzodiazepines therefore represent a promising class of therapeutic BET inhibitors.

SUBMITTER: Sharp PP

PROVIDER: S-EPMC5733269 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.

Sharp Phillip P PP Garnier Jean-Marc JM Hatfaludi Tamas T Xu Zhen Z Segal David D Jarman Kate E KE Jousset Hélène H Garnham Alexandra A Feutrill John T JT Cuzzupe Anthony A Hall Peter P Taylor Scott S Walkley Carl R CR Tyler Dean D Dawson Mark A MA Czabotar Peter P Wilks Andrew F AF Glaser Stefan S Huang David C S DCS Burns Christopher J CJ

ACS medicinal chemistry letters 20171114 12

A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromo ...[more]

PMID: 29259751

Dataset Information

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.

Publications

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
| S-EPMC5558211 | biostudies-literature

Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors.
| S-EPMC6071962 | biostudies-literature

Design, Synthesis, and Characterization of a Fluorescence Polarization Pan-BET Bromodomain Probe.
| S-EPMC6295860 | biostudies-literature

Novel Double-Modified Colchicine Derivatives Bearing 1,2,3-Triazole: Design, Synthesis, and Biological Activity Evaluation
| S-EPMC8515607 | biostudies-literature

Targeting Cancer Cells with BET Bromodomain Inhibitors.
| S-EPMC5495050 | biostudies-literature

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma.
| S-EPMC5596569 | biostudies-literature

Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors.
| S-EPMC5474678 | biostudies-literature

1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity.
| S-EPMC4255721 | biostudies-literature

Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.
| S-EPMC3748591 | biostudies-literature

The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors.
| S-EPMC6524770 | biostudies-literature